Indication
For the treatment of moderate to severe symptomatic vulvar and vaginal atrophy in post-menopausal women who are not candidates for local vaginal oestrogen therapy.

Medicine details

Medicine name:
ospemifene (Senshio)
SMC ID:
SMC2170
Pharmaceutical company
Shionogi Limited
BNF chapter
Endocrine system
Submission type
Full
Status
Advice due date:
09 September 2019
SMC meeting date:
06 August 2019
Patient group submission deadline:
01 July 2019